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OBJECTIVE—Low birth weight is consistently associated with
an increased risk of type 2 diabetes in adulthood, but the
individual contributions from poor fetal growth and preterm
birth are not known. We therefore investigated the signiﬁcance
of these two factors separately.
RESEARCH DESIGN AND METHODS—We identiﬁed a co-
hort of subjects born preterm or with low birth weight at term at
four major delivery units in Sweden from 1925 through 1949. A
comparison cohort of subjects was identiﬁed from the same
source population. Of 6,425 subjects in all, 2,931 were born at
37 weeks of gestation and 2,176 had a birth weight 2,500 g.
Disease occurrence among participants was assessed through
nationwide hospital registers from 1987 through 2006.
RESULTS—During follow-up, there were 508 cases of diabetes.
Low birth weight was strongly negatively associated with risk of
diabetes (P for trend 0.0001). Both short gestational duration
and poor fetal growth were associated with later diabetes (P for
trend 0.0001 and 0.0004, respectively). Very preterm birth
(32 weeks of gestation at birth) was associated with a hazard
ratio (HR) of 1.67 (95% CI 1.33–2.11) compared with term birth.
Birth weights below 2 SDs of mean birth weight for gestational
age were associated with an HR of 1.76 (1.30–2.38) compared
with birth weights between the mean weight and the weight at 1
SD above the mean.
CONCLUSIONS—Our results suggest that the association be-
tween low birth weight and diabetes is due to factors associated
with both poor fetal growth and short gestational age. Diabetes
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T
ype 2 diabetes affects hundreds of millions of
people worldwide, and the prevalence is rising
(1). Several studies have found an association
between low birth weight and type 2 diabetes
(2–12). The predominant explanation for this association
has been the so-called fetal origins hypothesis, which
suggests that fetal malnutrition induces adaptive changes
in fetal glucose metabolism that become lasting, thereby
contributing to an increased risk of type 2 diabetes and
heart disease in adult life (2,13).
The fetal origins hypothesis inherently assumes that low
birth weight indicates fetal growth restriction rather than
preterm birth. For ischemic heart disease and hyperten-
sion, this assumption has been found to be valid (14,15). In
the case of type 2 diabetes, no study has assessed the
hypothesis while distinguishing preterm birth from growth
restriction. Therefore, the validity of the fetal origins
hypothesis on risk of diabetes in adult life remains uncer-
tain (16,17).
In this study, we followed a cohort of 6,425 subjects
born between 1925 and 1949. We oversampled infants born
before the 35th gestational week or with low birth weight
to assess selective contributions from low birth weight
and short gestational duration to risk of type 2 diabetes.
RESEARCH DESIGN AND METHODS
The study cohort has been described in more detail previously (14). Within a
well-deﬁned source population, we manually examined 250,000 births
records from 1925 through 1949 and identiﬁed an exposed cohort by identi-
fying all newborn infants with a gestational duration 35 weeks and/or a birth
weight 2,000 g for girls and 2,100 g for boys. Subjects who emigrated or
deceased before 1987 were excluded. For unexposed cohort members, we
selected subjects who were not born preterm or with low birth weight. For
convenience, we selected the ﬁrst child born of the same sex and hospital of
birth as each exposed subject.
Perinatal deﬁnitions and categorization. We used the date of the mother’s
last menstrual period to estimate gestational duration. Birth weight for
gestational age was used as the measure of fetal growth. We used the Swedish
reference curve for normal fetal growth (18) and categorized birth weights for
gestational age into ﬁve groups according to their distance from the mean
birth weight for gestational age (2 SD or less, above 2t o1 SD, above 1
to 0 SD, above 0 to 1 SD, and above 1 SD). Subjects whose birth weight was
more than 4 SDs above or below the mean birth weight for gestational age
were excluded.
The socioeconomic status of the family was assessed by the father’s
occupation, or by the mother’s occupation in single-parent families, using
three categories: high (college education), medium (white-collar workers and
farm owners with no college education), and low (blue-collar workers
and farmhands).
Follow-up and analysis. The follow-up started on 1 January 1987 and
continued to 31 December 2006. We used the Swedish Register of Population
and Population Changes to ascertain emigration and the Cause of Death
Register to ascertain deaths. Diagnoses of diabetes were determined from the
Hospital Discharge Register, which lists one main diagnosis and up to seven
additional diagnoses. During the period 1987–1996, diagnoses were catego-
rized according to the ICD-9 and thereafter according to the ICD-10. We
considered cohort subjects as cases if they had a main or additional diagnosis
of diabetes with diagnostic code 250 before 1997 and diagnostic code E11
after 1997.
Data were modeled through conditional Cox regression, using the
TPHREG procedure in SAS Statistical Software (version 9.1; SAS Institute,
Cary, NC). Analyses were conditioned by calendar period of birth, socioeco-
nomic status, and sex. Additional adjustments for gestational duration and
fetal growth were also obtained by conditioning on these factors. Missing
information on socioeconomic status was treated as a separate category when
the analysis was stratiﬁed on this variable. The study was approved by the
research ethics committee of the Karolinska Institutet.
RESULTS
At the start of follow-up, there were 6,425 subjects in the
cohort. The distributions of birth weight, gestational du-
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Table 1. During follow-up, 508 subjects were treated as
inpatients with a main or an additional diagnosis of
diabetes. Calendar period of birth, socioeconomic status,
and sex were all associated with risk of diabetes (Table 2),
and all further analyses were adjusted for these three
variables.
Birth weight was strongly associated with risk of diabe-
tes (Table 3). Furthermore, both fetal growth and gesta-
tional duration were independently associated with risk of
diabetes (Table 3). To evaluate whether our choice of
reference curves affected the association between fetal
growth and risk of diabetes, we also analyzed the data with
all growth category limits shifted 50 and 100 g downwards
and upwards, but those alterations had no effect on the
results (data not shown).
The association of fetal growth and gestational duration
with risk of diabetes was not affected by calendar period
of birth (Table 3). Likewise, none of the variables for
maternal age, hypertensive diseases during pregnancy,
twin status, or breast-feeding at time of hospital discharge
were associated with risk when fetal growth or gestational
duration were included in the model (data not shown).
Table 4 describes an analysis of interaction between
fetal growth and gestational age on risk of diabetes. The
association between poor fetal growth and diabetes was
independent of gestational age, and likewise the associa-
tion between low gestational age and diabetes was inde-
pendent of fetal growth.
DISCUSSION
This is the ﬁrst study large enough to assess the individual
contributions of fetal growth and length of gestation on
risk of diabetes in adult life with appropriate statistical
precision. Our data conﬁrm the previously reported in-
verse association between birth weight and adult diabetes
(2–12) and add the evidence that short gestational dura-
tion and fetal growth restriction are both independently
associated with an increased risk of diabetes.
Our study is population based, information about birth
characteristics was based on prospectively collected data,
and follow-up was uniform across comparison groups
through the use of register data. It is therefore unlikely, if
not precluded, that measurement errors should vary be-
tween subjects with and without diabetes.
One limitation is the expanse of time between the
subjects’ dates of birth and the beginning of the follow-up.
Study subjects were born between 1925 and 1949, but the
follow-up did not start until 1987. The cohort therefore
consists of subjects born 50 years ago who survived to
37–62 years of age. Another limitation was our inability to
test whether the association between birth weight and
diabetes might be explained by a common genetic etiology
(19). A third limitation of our study is the lack of struc-
tured data on the neonatal care of these subjects, and so
there can only be speculation as to what extent the
knowledge derived from this cohort from the early 1900s
applies to today’s newborns.
In our cohort, 70% of the subjects born at 33 weeks
of gestation had a birth weight for gestational age that was
above average. Selective survival favoring non–growth-
restricted subjects among those born preterm may partly
explain this skewness (20) and may have biased the
obtained associations. However, childhood mortality de-
clined steeply in Sweden from 1925 to 1949, whereas our
risk estimates were fairly stable across birth cohorts.
Thus, we think that selective survival is an unlikely
explanation for our ﬁndings.
We used information on the mother’s last menstrual
period to estimate gestational age, which may lead to
some misclassiﬁcation. By excluding all subjects whose
birth weight deviated more than 4 SDs from the mean birth
weight for gestational age category, misclassiﬁcation was
reduced. Fetal growth was estimated through growth
curves from ultrasonographically dated pregnancies from
the 1990s. Reassuringly, our results remained unchanged
when we altered the cutoff levels for the deﬁnition of fetal
growth rate, indicating that the choice of reference curves
does not affect the association.
Subjects in our cohort were registered as diabetic if they
had required hospitalization, and because diabetes is fre-
quently diagnosed in open clinics, we are likely to have
underestimated the true incidence of diabetes. The abso-
lute occurrence of diabetes in the study is therefore not
TABLE 1
Cohort subjects by gestational duration, birth weight, and
fetal growth
Gestational duration
32
weeks
33–36
weeks
37–42
weeks
43
weeks Total
Birth weight (g)
1,500 132 19 0 0 151
1,500–1,999 403 392 39 1 835
2,000–2,499 307 716 161 6 1,190
2,500–2,999 144 454 377 25 1,000
3,000–3,499 0 252 1,045 70 1,367
3,500–3,999 0 110 1,105 94 1,309
4,000 0 2 494 77 573
Total 986 1,945 3,221 273 6,425
Fetal growth (SD)
2 or less 26 256 255 39 576
More than 2t o1 94 240 522 86 942
More than 1 to 0 219 416 1,114 87 1,836
More than 0 to 1 208 400 902 50 1,560
More than 1 439 633 428 11 1,511
Total 986 1,945 3,221 273 6,425
Data are n.
TABLE 2
HRs for diabetes by calendar period of birth, socioeconomic
status, and fetal sex
Diabetes according to ICD-9: 250
and ICD-10: E11
n
Cases
(n)
Crude
HR CI
Calendar period of birth
1925–1929 936 117 4.72 3.39–6.58
1930–1934 975 134 4.85 3.50–6.71
1935–1939 1,586 124 2.50 1.80–3.48
1940–1944 1,426 83 1.81 1.27–2.57
1945–1949 1,502 50 1 Ref.
Socioeconomic status
High 309 13 0.45 0.26–0.79
Medium 912 47 0.57 0.42–0.77
Low 5,120 446 1 Ref.
Sex
Male 3,819 360 1.78 1.47–2.15
Female 2,606 148 1 Ref.
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could not be inﬂated but, rather, could be biased toward
unity by such underestimation.
In this study, follow-up did not cover the entire life span
of the subjects. For subjects born in 1925, follow-up
started at the age of 61 years, whereas for subjects born in
1949, it stopped at the age of 57 years. Because risk
estimates were similar regardless of birth period, we ﬁnd
it unlikely that this truncated follow-up has had more than
a marginal inﬂuence on our results.
The fetal origins hypothesis suggests that fetal undernu-
trition during middle and late gestation triggers lasting
hormonal and metabolic adaptations that ultimately lead
to insulin resistance and diabetes (13,19,21). Our ﬁnding
that not only fetal growth restriction but also short gesta-
tional duration contribute to the risk of diabetes is not
entirely compatible with that hypothesis. It suggests,
rather, that the association between low birth weight and
diabetes has two components: one component mediated
through poor fetal growth and the other through preterm
birth. It cannot be ruled out that the effect on glucose
metabolism of preterm birth and fetal growth share a
common mechanistic pathway. It could, for example, be
speculated that the association between low birth weight
and diabetes could be due to postnatal nutritional expo-
sures, both in those born small for gestational age and
those born preterm. Unfortunately, we were unable to
assess postnatal diet and infant growth in the present data.
Previous studies have found results consistent with
ours. In a study on insulin resistance, Hofman et al. (16)
found that infants born preterm and with appropriate
weight for gestational age faced the same increase in risk
of insulin resistance as did infants born small for gesta-
tional age at term. In a recent study of Hovi at al. (17), the
authors found that preterm infants with very low birth
weight (1,500 g) showed similar patterns of glucose
TABLE 3
HRs for diabetes by birth weight, fetal growth, and gestational duration
All Birth year 1925–1939 Birth year 1940–1949
n
Age at
onset
(years)
Cases
(n)H R C I n
Cases
(n)H R C I n
Cases
(n)H R C I
Birth weight (g)
1,500 151 57.8  9.6 17 1.97 1.17–3.31 74 8 1.27 0.61–2.66 77 9 3.82 1.79–8.18
1,500–1,999 835 62.2  8.7 95 1.77 1.33–2.37 468 71 1.81 1.29–2.55 367 24 1.65 0.95–2.86
2,000–2,499 1,190 61.8  8.6 120 1.45 1.10–1.90 680 90 1.48 1.08–2.04 510 30 1.36 0.81–2.29
2,500–2,999 1,000 61.8  8.3 79 1.13 0.84–1.53 559 57 1.14 0.80–1.63 441 22 1.11 0.63–1.96
3,000–3,499 1,367 61.8  9.3 94 1 Ref. 740 67 1 Ref. 627 27 1 Ref.
3,500–3,999 1,309 63.7  8.2 71 0.78 0.57–1.07 686 57 0.88 0.62–1.25 623 14 0.55 0.29–1.04
4,000 573 62.9  8.0 32 0.80 0.54–1.20 290 25 0.92 0.58–1.45 283 7 0.54 0.24–1.25
Total 6,425 62.0  8.6 508 3,497 375 2,928 133
P for trend 0.0001 0.0001 0.0001
Fetal growth (SD)
2 or less 576 62.2  8.9 70 1.76 1.30–2.38 329 56 1.72 1.22–2.41 247 14 1.88 0.96–3.67
More than 2t o1 942 61.6  9.8 93 1.43 1.08–1.89 498 58 1.13 0.81–1.58 444 35 2.58 1.51–4.41
More than 1 to 0 1,836 62.1  8.4 121 0.94 0.73–1.23 985 91 0.89 0.66–1.19 851 30 1.16 0.67–2.02
More than 0 to 1 1,560 62.5  8.1 107 1 Ref. 824 85 1 Ref. 736 22 1 Ref.
More than 1 1,511 61.6  8.4 117 1.05 0.81–1.37 861 85 0.93 0.69–1.25 650 32 1.55 0.90–2.67
Total 6,425 62.0  8.6 508 3,497 375 2,928 133
P for trend 0.0004 0.003 0.04
Gestational duration
(weeks)
32 986 60.9  8.2 109 1.67 1.33–2.11 555 74 1.47 1.11–1.95 431 35 2.82 1.77–4.48
33–36 1,945 62.1  8.7 168 1.29 1.05–1.58 1,098 129 1.29 1.02–1.64 847 39 1.51 0.96–2.38
37–42 3,221 62.4  8.9 216 1 Ref. 1,718 161 1 Ref. 1,503 55 1 Ref.
43 273 62.0  7.0 15 0.92 0.55–1.56 126 11 1.03 0.56–1.90 147 4 0.76 0.23–2.44
Total 6,425 62.0  8.6 508 3,497 375 2,928 133
P for trend 0.0001 0.004 0.0001
Data are means  SD unless otherwise indicated. Analyses are adjusted for calendar period of birth, socioeconomic status, and sex.
TABLE 4
HRs for the joint effect of fetal growth and gestational duration on risk of diabetes
Gestational duration
32 weeks 33–36 weeks 37–42 weeks 43 weeks
Fetal growth (SD)
2 or less 0.82 (0.11–5.98) 2.24 (1.42–3.53) 2.24 (1.45–3.45) 1.93 (0.69–5.36)
More than 2t o1 3.43 (1.94–6.05) 1.87 (1.16–3.03) 1.52 (1.02–2.28) 1.24 (0.53–2.90)
More than 1 to 0 2.21 (1.37–3.56) 1.31 (0.84–2.05) 0.95 (0.66–1.39) 0.45 (0.11–1.87)
More than 0 to 1 2.05 (1.26–3.32) 1.35 (0.86–2.12) 1 (ref) 0.46 (0.06–3.33)
More than 1 1.58 (1.04–2.39) 1.31 (0.88–1.94) 0.91 (0.56–1.49) 4.30 (1.04–17.9)
Data are HR (95% CI). Analyses are adjusted for calendar period of birth, socioeconomic status, and sex.
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they were born small or appropriately sized for gestational
age.
In a recent meta-analysis on the association between
birth weight and diabetes, Harder et al. (22) reported an
additional association between high birth weight and risk
of diabetes. We did not ﬁnd such an association in our
data, but our study was designed to study the risks in the
lower end of the birth-weight spectrum, and consequently
we lacked the power to assess the association between
high birth weight and risk of diabetes with precision.
Consistent with the fetal origins hypothesis, we have
previously found that the association between low birth
weight and risk of both ischemic heart disease and hy-
pertension was entirely mediated through poor fetal growth
(14,15). The risk patterns in the present analysis are, how-
ever, distinct from our ﬁndings on heart disease and hyper-
tension, suggesting that different mechanisms are involved
in the perinatal origins of these diseases.
In conclusion, we have found that the association be-
tween low birth weight and risk for diabetes seems to be
mediated through both poor fetal growth and preterm
birth. The underlying programming mechanisms seem to
involve not only prenatal but also postnatal factors.
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